Memews About
health

πŸ’‰ Takeda plants dengue vaccine in India playbook

Takeda Pharmaceutical is leveraging its new dengue vaccine, Qdenga, as a key growth area in India. The company plans to launch Qdenga in the first half of calendar 2027 across India. Dengue cases are a massive issue, with 233,519 reported cases in 2024 alone. Initially, sales will be private, aiming later for the National Immunisation Programme. Takeda is also investing in local production to ensure broad and equitable access to the vaccine. πŸ’‰

#TakedaIndia#DengueVax#PublicHealth
india

😠 Misogyny in Maharashtra politics continues

Maharashtra's NCP protested the Congress for calling Deputy CM Sunetra Pawar a "Goongi Gudiya" or "dumb doll". This incident occurred after a press conference in Beed, Marathwada, on August 05, 2026. The Congress refused to apologize despite the backlash, instead challenging Pawar to prove her worth. This reflects a wider trend of sexist comments in Maharashtra politics, similar to past incidents. The NCP has now questioned the Congress leadership about endorsing this culture.

#MaharashtraPolitics#GenderBias#PoliticalDrama
tech

πŸ’Έ Macbook prices getting pricier because of chip shortage

Macbook prices are increasing because of a global shortage of computer chips, largely driven by AI data center demands. This issue affects companies like Apple, Sony, and Dell, with a Macbook Air standard configuration jumping from $1,099 to $1,299. Experts predict consumer electronics prices will rise significantly next year due to this AI memory supercycle. The shortage is critical because only three companies build high-end memory chips for these devices. Companies are now trying to build new capacity, but prices are expected to keep climbing.

#TechPrices#ChipShortage#AIImpact
health

🦟 Tamil Nadu preps for monsoon disease risks

Health Minister K.G. Arunraj held a meeting to review preparedness against monsoon-related diseases. Officials from various departments, including Rural Development and Water Resources Minister N. Anand, were present in Tamil Nadu. The state has intensified fever surveillance across 5,781 hospitals, with 4,083 labs required to upload daily data since August 5, 2026. The focus remains on preventing dengue from stagnant water and managing diarrheal diseases through water chlorination. 38 District and 385 Block Rapid Response Teams are fully ready for immediate disease outbreak containment. 🦟

#TamilNaduHealth#MonsoonPrep#DiseaseControl
tech

πŸ€– Meta execs meet Indian IT ministry over PM Modi video

Senior global executives from Meta are set to meet MeitY officials on August 5 and 6. This meeting follows the temporary removal of a video posted by Prime Minister Narendra Modi on July 28. Discussions will cover non-compliance with Indian laws, CSAM, and safeguards for verified accounts. MeitY is also concerned because Meta's India policy team allegedly failed to communicate government concerns to US leadership. The meeting comes after demands for an apology from Meta's CEO over the video takedown. 🧐

#MetaIndia#MeitY#DigitalIndia
health

🩺 Chennai hospital launches advanced liver suite

Gleneagles Hospital in Chennai has introduced a new, dedicated liver OPD suite for comprehensive care. This specialized clinical hub caters to all stages of liver disease across every age group. The facilities offer pediatric hepatology and care for MASLD, alongside integrated hepatorenal pathways. It also features a dedicated service for liver cancer diagnosis and treatment. Actor RJ Balaji inaugurated this advanced facility on Tuesday, August 5, 2026.

#ChennaiHealth#LiverCare#HealthcareTech
health

πŸ”¬ Biosimilar Denosumab beats bisphosphonates in cost study

A study by the Center for Biosimilars found that biosimilar denosumab is more cost-effective compared to traditional bisphosphonates. This comparison was conducted within the context of the Public Medical Organization (PMO). The research covered data up to the present, highlighting significant savings potential. This finding suggests a shift in treatment protocols for certain conditions. Health authorities are now expected to review these cost-efficiency data points.

#Biosimilars#Healthcare#CostSaving
india

πŸ“’ CPI MP urges PM Modi to drop cases on protesters

CPI Rajya Sabha member P. Sandosh Kumar wrote to Prime Minister Narendra Modi demanding an end to harassment of students. The protests were against the NEET paper leak, and the harassment involved RSS workers and BJP leaders in New Delhi. Specific incidents mentioned include threats at Connaught Place and social pressure at homes, reported around August 05, 2026. Kumar argued that students exercised their democratic right but faced intimidation instead of acknowledgment. He insisted that all cases against the protesting students must be withdrawn immediately.

#CPIMovement#StudentProtest#IndianPolitics
science

πŸ›°οΈ Starlink data mapping the upper atmosphere

Researchers are using publicly available Starlink satellite data to map the Earth's upper atmosphere. The study was conducted by a team of scientists who utilized the extensive network of Starlink satellites. This data collection effort spans observations made over several months. The research aims to better understand atmospheric dynamics and changes in the upper layers. Future studies will likely use this enhanced data for more detailed climate modeling. πŸ›°οΈ

#SpaceScience#Starlink#Atmosphere
business

πŸ€– Microsoft ditches peer feedback tool for review overhaul

Microsoft is retiring its 'Perspectives' peer-feedback tool as it revamps its entire employee review system. This tool, which allowed peer input visible to employees and managers, has been in use since 2018. The tool is no longer open for new requests, but existing feedback can be exported until September 15th. The change signals a shift towards more informal, in-the-moment conversations between colleagues. This move aligns with Microsoft's broader performance review simplification and organizational flattening efforts. πŸ€–

#Microsoft#TechUpdate#WorkCulture
health

πŸ”¬ New HIV Drug Shows Less Weight Gain Than Old Combo

A study published in JAMA found that the Doravirine-based HIV regimen resulted in less weight gain compared to the dolutegravir combination. This trial involved participants who were monitored in a clinical setting. The results were tracked across a specific study period involving multiple individuals. This finding is important for managing long-term side effects in HIV treatment. Researchers will continue monitoring these drug regimens closely going forward. πŸ”¬

#HIVresearch#DrugTrial#HealthScience

j / k or ↑ ↓ to move Β· space for next

Preview of the card that will be shared